Chemotherapie-induced oral mucositis K12.1
Conditions
Interventions
Group 1: Transaction of the Nursing-based Oral Care Program for preventing oral mucositis
Group 2: one-time short information about the risk of oral mucosotis in the informational conversation before
Sponsors
Hochschule Furtwangen
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients, who consent to the participation of the study Patients with solid Tumors legal capacity 5-Fluorouracil Chemotherapy with a dose > 400mg/m2 body surface area per application
Exclusion criteria
Exclusion criteria: Patients who could not consent to the participation of the study Patients coeval enclosed to another RCT Patients who addict drugs and/or alcohol Patients who have infectious disease Patients who got a chemptherapie within last 6 month Patients who get head or neck-radiotherapy Patients with an acute oral mucositis before beginning of chemotherapie Long distances to patients domicile
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Appearance of an oral mucositis (WHO 1 or higher) beetween day 8 an 12 after first, second and third application of chemotherapie | — |
Secondary
| Measure | Time frame |
|---|---|
| Intesity and duration of oral mucositis Oral health releated quality of life Activities of oral hygiene adherence | — |
Countries
Germany
Contacts
Public ContactPeter König
Hochschule Furtwangen
Outcome results
None listed